Skip to main content

Find Clinical Trials

Home
Conditions
Prostatic Neoplasms

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,735 public trials 964 recruiting studies

Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Recruiting

Two Fraction Prostate SBRT With DIL SIB

NCT05864196

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: NYU Langone Hospital - Long Island Mineola, New York, United States

NYCyberKnife at Perlmutter Cancer Center New York, United States

View Trial Details

Recruiting

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

NCT07210086

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

NCT04734730

Conditions: Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

NCT06397703

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: NYU Langone Health New York, United States

View Trial Details

Recruiting

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

NCT06145633

Conditions: Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.

NCT07370597

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: Institut Jules Bordet Brussels, Belgium

View Trial Details

Recruiting

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

NCT04402151

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Recruiting

Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

NCT07363486

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

NCT07363382

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +34 more
Locations: Scottsdale Medical Imaging, LLC Scottsdale, Arizona, United States

Yale University School of Medicine New Haven, Connecticut, United States

University of Chicago Medical Center Chicago, Illinois, United States

Methodist Medical Center of Illinois Peoria, Illinois, United States

View all 51 locations

View Trial Details